loading…
XW133F8 Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
BackXW13325Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5→XW1337ATransfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10→XW133B8Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8→XW133C8Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8→XW133D7Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7→XW133E7Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7→XW133F8Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8→XW133G8Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8→XW133H9Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9→XW133J8Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8→XW133SBTransfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11→XW133YBTransfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11→XW14325Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5→XW1437ATransfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10→XW143B8Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8→XW143C8Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8→XW143D7Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7→XW143E7Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7→XW143F8Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8→XW143G8Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8→XW143H9Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9→XW143J8Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8→XW143SBTransfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11→XW143YBTransfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11→
Procedure codeCODABLE
XW133F8
Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
DESCRIPTION
Putting in blood or blood products
- Part
- ICD-10-PCS
- X
- New Technology
- XW
- Anatomical Regions
- XW1
- Transfusion
Source
CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.